• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Carrie Stricker Discusses IT Solutions That Engage Both Cancer Patients and Care Teams

Video

Innovative health IT tools like those developed by Carevive help maximize the balance between patient self-management and care team engagement, which is especially important in the era of value-based care, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

Innovative health IT tools like those developed by Carevive help maximize the balance between patient self-management and care team engagement, which is especially important in the era of value-based care, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

Transcript (slightly modified)

How does Carevive use health IT to develop innovative solutions for cancer care providers?

Carevive’s approach to innovative solutions in cancer care is to develop tools that help maximize that balance between patient self-management and care team engagement across the care continuum. So as we are rapidly moving into this era of value-based care, where cancer care teams are going to be held accountable to patient outcomes and costs, engaging the patient in their own care has been shown again and again in a number of studies to improve not only patient outcomes but also decrease cost. And so we need to get that piece of the puzzle right, but we need to also ensure that the care teams know when to engage with the patient, when that patient is at risk, when they’re moving outside that area of being able to manage their own healthcare.

So we do that through innovative solutions that in a validated and highly tailored fashion ask patients about their symptoms, their functional status, their concerns, their goals for their care and their quality of life throughout their cancer experience, and then give them the tools they need to self-manage symptoms as they’re starting to progress. To know when to call the care team as symptoms, function, and other issues are worsening, and then to engage the entire care team—not just the physician or the nurse or the advanced practice provider in the clinical visit at the point of care where you’ve got that 15 minute, at most, visit.

We also have the tools to ensure that those patients who are running into trouble between visits get the attention from the care team that they need, by actively alerting those care providers.

Related Videos
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Screenshot of Susan Wescott, RPh, MBA
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Screenshot of an interview with Adam Colborn, JD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.